Essential Partners’s Sionna Therapeutics SION Stock Holding History

Essential Partners’s Portfolio SION Stock Details SION Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.72K	Buy	+326	New	+$7.49K	﹤0.01%	1977

Other funds holding SION

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Owl Creek Wealth Partners Denver, Colorado $355M AUM

Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Contravisory Investment Management Norwell, Massachusetts $552M AUM 32.44% 1-Year Est. Return

Essential Partners's SION Position: Q3 2026 in Review

Essential Partners opened a new position in Sionna Therapeutics (SION) in Q3 2026: 326 shares worth $1.72K. The stake represents ﹤0.01% of the portfolio and ranks #1977 among its holdings.

11 funds tracked by Wall St. Rank hold SION as of Q3 2026.

Essential Partners held 326 shares of Sionna Therapeutics worth $1.72K as of Q3 2026.
Sionna Therapeutics was a new Essential Partners position in Q3 2026.
Sionna Therapeutics made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #1977 holding.
11 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.